These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3569377)

  • 1. Bacterial resistance and single-dose therapy of urinary tract infections.
    Satta G; Caredda M; Pruna M; Pompei R
    Eur Urol; 1987; 13 Suppl 1():42-4. PubMed ID: 3569377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
    Burgos RM; Rodvold KA
    Future Microbiol; 2019 Apr; 14():461-475. PubMed ID: 30854892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day nitrofurantoin is better than single-dose fosfomycin at resolving UTI symptoms.
    Drug Ther Bull; 2018 Nov; 56(11):131. PubMed ID: 30297448
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral and intravenous fosfomycin in complicated urinary tract infections.
    López-Montesinos I; Horcajada JP
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):37-44. PubMed ID: 31131591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin: A Revisited Antibiotic for Urinary Tract Infections.
    Parikh FS
    J Assoc Physicians India; 2017 Sep; 65(9):11. PubMed ID: 29313569
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections.
    Ceran N; Mert D; Kocdogan FY; Erdem I; Adalati R; Ozyurek S; Goktas P
    J Infect Chemother; 2010 Dec; 16(6):424-30. PubMed ID: 20585969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with fosfomycin in urinary tract infections (author's transl)].
    Peters HJ; Eicher R
    MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of fosfomycin in the management of urinary tract infections].
    Zaitsev AV; Kolontarev KB
    Urologiia; 2017 Sep; (4):91-96. PubMed ID: 28952700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria.
    Neuman M; Rufin F
    Eur Urol; 1987; 13 Suppl 1():105-7. PubMed ID: 3552693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.
    Grayson ML; Macesic N; Trevillyan J; Ellis AG; Zeglinski PT; Hewitt NH; Gardiner BJ; Frauman AG
    Clin Infect Dis; 2015 Oct; 61(7):1141-3. PubMed ID: 26063723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.
    Rosso-Fernández C; Sojo-Dorado J; Barriga A; Lavín-Alconero L; Palacios Z; López-Hernández I; Merino V; Camean M; Pascual A; Rodríguez-Baño J;
    BMJ Open; 2015 Mar; 5(3):e007363. PubMed ID: 25829373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fosfomycin for urogenital tract infections: Advances in studies].
    Mo DS; Liu W; Shang XJ; Zheng DD
    Zhonghua Nan Ke Xue; 2015 May; 21(5):467-71. PubMed ID: 26117948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin in treatment of chronic urinary tract infection.
    Gobernado M; Oleza J; Santos M; Roman J; Paz M; Mascaros E; Almela J
    Chemotherapy; 1975; 21(2):99-107. PubMed ID: 1157571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of urinary tract infections across age groups.
    Chu CM; Lowder JL
    Am J Obstet Gynecol; 2018 Jul; 219(1):40-51. PubMed ID: 29305250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?
    Cai T; Cocci A; Verze P; Rizzo M; Palmieri A; Liguori G; Trombetta C; Adembri C; Carini M; Bartoletti R; Wagenlehner FM; Bonkat G; Mirone V; Bjerklund Johansen TE; Novelli A
    J Chemother; 2018 Sep; 30(5):290-295. PubMed ID: 30843774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
    Patel SS; Balfour JA; Bryson HM
    Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.